Loading...
Ionis Pharmaceuticals, Inc.
IONS•NASDAQ
Healthcare
Biotechnology
$42.25
$0.10(0.24%)
Ionis Pharmaceuticals, Inc. (IONS) Financial Performance & Income Statement Overview
Review Ionis Pharmaceuticals, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.48%
↓ 10.48%
Operating Income Growth
-34.31%
↓ 34.31%
Net Income Growth
-23.92%
↓ 23.92%
Operating Cash Flow Growth
-62.90%
↓ 62.90%
Operating Margin
-65.85%
↓ 65.85%
Gross Margin
97.75%
↑ 97.75%
Net Profit Margin
-63.84%
↓ 63.84%
ROE
-92.06%
↓ 92.06%
ROIC
-18.44%
↓ 18.44%
Ionis Pharmaceuticals, Inc. (IONS) Income Statement & Financial Overview
Review Ionis Pharmaceuticals, Inc.'s (IONS) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $226.58M | $134.00M | $225.25M | $119.50M |
| Cost of Revenue | $3.83M | $1.07M | $9.74M | $7.80M |
| Gross Profit | $222.75M | $132.93M | $215.51M | $111.69M |
| Gross Profit Ratio | $0.98 | $0.99 | $0.96 | $0.93 |
| R&D Expenses | $245.49M | $219.76M | $222.06M | $214.22M |
| SG&A Expenses | $88.10M | $61.60M | $59.53M | $46.99M |
| Operating Expenses | $333.57M | $281.40M | $281.60M | $261.21M |
| Total Costs & Expenses | $337.40M | $282.47M | $291.34M | $269.01M |
| Interest Income | -$1.60M | $2.23M | $0.00 | $49000.00 |
| Interest Expense | $21.27M | $21.23M | $22.79M | $20.56M |
| Depreciation & Amortization | $5.27M | $23.66M | $5.58M | $5.65M |
| EBITDA | -$80.50M | -$125.00M | -$37.84M | -$114.97M |
| EBITDA Ratio | -$0.36 | -$0.93 | -$0.17 | -$0.96 |
| Operating Income | -$110.82M | -$148.66M | -$66.09M | -$149.51M |
| Operating Income Ratio | -$0.49 | -$1.11 | -$0.29 | -$1.25 |
| Other Income/Expenses (Net) | $3.78M | $4.55M | -$110000.00 | $6.79M |
| Income Before Tax | -$107.04M | -$144.10M | -$66.20M | -$142.73M |
| Income Before Tax Ratio | -$0.47 | -$1.08 | -$0.29 | -$1.19 |
| Income Tax Expense | -$2.69M | -$4.00M | $64000.00 | $75000.00 |
| Net Income | -$104.35M | -$140.48M | -$66.27M | -$142.80M |
| Net Income Ratio | -$0.46 | -$1.05 | -$0.29 | -$1.20 |
| EPS | -$0.66 | -$0.95 | -$0.45 | -$0.98 |
| Diluted EPS | -$0.66 | -$0.95 | -$0.45 | -$0.98 |
| Weighted Avg Shares Outstanding | $158.00M | $148.59M | $145.96M | $145.54M |
| Weighted Avg Shares Outstanding (Diluted) | $158.00M | $148.59M | $145.96M | $145.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan